Literature DB >> 1309207

Successful management of inferior vena cava and right atrial nephroblastoma tumor thrombus with preoperative chemotherapy.

H F Oberholzer1, G Falkson, L C De Jager.   

Abstract

Involvement of inferior vena cava (IVC) by tumor thrombus occurs in up to 10% of patients with nephroblastoma. Right atrial involvement by tumor thrombus is much less frequent. Four patients presenting with advanced nephroblastoma were diagnosed as having IVC involvement with tumor thrombus. Two of these patients had in addition thrombus extending up to the right atrium. All 4 patients were treated with preoperative chemotherapy (vincristine, actinomycin D, 4-epi-Adriamycin). Nephrectomy was subsequently performed without undue difficulty on all 4 patients. The intravascular tumor thrombus had completely cleared in all 4 patients and most of the primary renal tumor was necrotic. The results obtained with preoperative chemotherapy as given to these patients mediates strongly against difficult surgery being undertaken as primary treatment for such patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309207     DOI: 10.1002/mpo.2950200113

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

Review 1.  Wilms' tumor.

Authors:  R P Warrier; O Regueira
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

2.  Successful treatment of intracaval and atrial extension of Wilms' tumour by chemotherapy.

Authors:  S Berberoğlu; C Akyüz; M Büyükpamukçu
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 3.  Current treatment and prognosis of Wilms' tumor.

Authors:  O Regueira; R P Warrier; L C Yu; D L Ode
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

4.  Intravascular extension of Wilms tumor.

Authors:  R C Shamberger; M L Ritchey; G M Haase; T L Bergemann; T Loechelt-Yoshioka; N E Breslow; D M Green
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.